2007
DOI: 10.1093/nar/gkm1021
|View full text |Cite
|
Sign up to set email alerts
|

PRIDE: new developments and new datasets

Abstract: The PRIDE (http://www.ebi.ac.uk/pride) database of protein and peptide identifications was previously described in the NAR Database Special Edition in 2006. Since this publication, the volume of public data in the PRIDE relational database has increased by more than an order of magnitude. Several significant public datasets have been added, including identifications and processed mass spectra generated by the HUPO Brain Proteome Project and the HUPO Liver Proteome Project. The PRIDE software development team h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
117
0
1

Year Published

2009
2009
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 131 publications
(118 citation statements)
references
References 28 publications
0
117
0
1
Order By: Relevance
“…However, protocols or modification within protocols had to be annotated. Data [8,9]) serving as reference data for future analysis.…”
Section: Introductionmentioning
confidence: 99%
“…However, protocols or modification within protocols had to be annotated. Data [8,9]) serving as reference data for future analysis.…”
Section: Introductionmentioning
confidence: 99%
“…We identified 1,429 phosphoproteins and 3,029 unique phosphopeptides at a false discovery rate of 0.44% for MASCOT and 0.12% for INSPECT searches and established the exact sites of phosphorylation in 2,349 peptides (Table I; Supplemental Tables S1-S3). Details of peptide assignment, together with the original spectra, are publicly available in the PRIDE database (www.ebi.ac.uk/pride/prideMart.do; Jones et al, 2008). Our data set is comparable in size to the phosphoproteome data set reported recently by Sugiyama et al (2008).…”
Section: The Arabidopsis Phosphoproteomementioning
confidence: 99%
“…For example, many algorithms and software tools have been developed to expedite assay development by aiding in the selection of proteotypic peptides (31), peptide transitions, and instrument parameters (reviewed in Cham Mead et al (32)). Additionally, through community effort, several publicly available databases of tandem MS spectra (33)(34)(35)(36)(37)(38)(39) and validated SRM assays (40,41) are available to provide empirical guides to transition selection and assay development. Several groups have also presented elegant solutions to maximize instrument duty cycle and improve assay specificity.…”
mentioning
confidence: 99%